C

Chorokbaem Healthcare Co Ltd
KRX:118000

Watchlist Manager
Chorokbaem Healthcare Co Ltd
KRX:118000
Watchlist
Price: 241 KRW -2.03% Market Closed
Market Cap: ₩41.4B

Balance Sheet

Balance Sheet Decomposition
Chorokbaem Healthcare Co Ltd

Balance Sheet
Chorokbaem Healthcare Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
675
588
2 179
6 099
216
836
275
300
1 395
35 209
18 229
14 705
59 236
28 471
20 083
30 061
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
Cash Equivalents
675
588
2 179
6 099
216
836
275
300
1 395
35 209
18 229
14 705
59 236
28 471
20 081
30 061
Short-Term Investments
1 571
2 951
12 651
131
2 897
164
215
10 000
16
0
10 000
0
0
1 267
1 289
55
Total Receivables
25 139
29 890
28 499
13 874
4 608
7 519
3 062
4 224
15 828
11 473
12 359
12 282
19 482
25 972
19 177
10 973
Accounts Receivables
21 888
26 485
25 395
12 417
3 599
5 630
1 931
2 513
15 221
11 193
10 273
4 914
6 286
14 529
12 920
8 942
Other Receivables
3 251
3 405
3 104
1 457
1 009
1 889
1 131
1 711
607
280
2 086
7 368
13 196
11 443
6 257
2 031
Inventory
1 637
2 005
3 121
1 584
1 775
1 110
2 030
1 245
4 002
5 592
3 902
3 270
1 694
15 825
9 237
988
Other Current Assets
2 151
2 891
1 204
378
171
921
971
233
4 866
1 998
1 099
4 207
2 021
1 937
3 482
1 101
Total Current Assets
31 173
38 325
47 654
22 066
9 667
10 551
6 554
16 002
26 107
54 272
45 589
34 464
82 433
73 473
53 267
43 178
PP&E Net
212
7 363
2 766
1 977
1 423
1 288
2 149
977
2 883
2 484
2 411
1 689
298
1 618
1 891
2 864
PP&E Gross
212
7 363
2 766
1 977
1 423
1 288
2 149
977
2 883
2 484
2 411
1 689
298
1 618
1 891
2 864
Accumulated Depreciation
429
490
1 737
2 683
3 809
4 504
3 922
3 967
5 304
5 438
1 325
1 153
263
3 891
3 535
501
Intangible Assets
0
3 167
1 494
1 497
2 507
2 369
2 097
1 839
2 386
1 395
1 390
88
7 884
16 609
12 837
4 251
Goodwill
0
0
0
0
4 350
1 806
1 806
0
1 841
631
631
0
4 946
14 974
14 853
4 935
Note Receivable
0
0
0
0
0
0
0
294
255
21
19
16
1 314
461
227
22
Long-Term Investments
10 937
37 881
5 406
4 441
2 368
2 321
2 251
8 548
2 041
1 911
19 311
101 268
79 169
79 412
70 488
101 304
Other Long-Term Assets
1 928
785
770
408
1 654
1 338
1 548
1 185
1 228
727
455
768
258
3 308
1 743
143
Other Assets
0
0
0
0
4 350
1 806
1 806
0
1 841
631
631
0
4 946
14 974
14 853
4 935
Total Assets
44 250
N/A
87 521
+98%
58 090
-34%
30 389
-48%
21 968
-28%
19 673
-10%
16 405
-17%
28 845
+76%
36 741
+27%
61 440
+67%
69 805
+14%
138 293
+98%
176 303
+27%
189 857
+8%
155 305
-18%
156 697
+1%
Liabilities
Accounts Payable
7 191
6 395
12 624
4 690
221
865
681
801
3 271
4 473
4 580
4 312
2 343
5 881
3 699
3 285
Accrued Liabilities
226
237
834
337
174
395
512
609
913
259
192
148
246
447
1 560
213
Short-Term Debt
7 830
22 410
10 726
1 800
2 955
1 211
783
1 353
8 757
8 460
4 370
1 888
0
8 953
2 000
0
Current Portion of Long-Term Debt
4 696
3 972
14 645
124
112
6 034
2 256
7 348
0
21 909
18 487
23 377
29 678
15 536
1 140
7 350
Other Current Liabilities
179
3 087
2 579
872
2 229
2 522
2 702
1 974
4 173
7 405
5 572
29 107
21 015
17 634
7 561
1 100
Total Current Liabilities
20 122
36 101
41 408
7 822
5 690
11 029
6 933
12 085
17 114
42 505
33 201
58 832
53 282
48 450
15 959
11 948
Long-Term Debt
0
28 527
0
0
0
0
0
0
0
0
155
430
175
10 552
214
28 222
Deferred Income Tax
213
0
0
0
0
0
0
0
54
0
74
659
0
783
639
0
Minority Interest
0
0
0
0
343
150
0
0
188
120
117
85
3 403
30 347
31 802
0
Other Liabilities
123
250
127
163
233
329
3 286
3 324
863
424
440
2 246
43
484
784
852
Total Liabilities
20 458
N/A
64 878
+217%
41 536
-36%
7 985
-81%
6 266
-22%
11 508
+84%
10 220
-11%
15 408
+51%
18 219
+18%
43 049
+136%
33 986
-21%
62 252
+83%
56 903
-9%
90 616
+59%
49 397
-45%
41 022
-17%
Equity
Common Stock
21 179
21 946
27 736
39 924
39 924
4 237
5 428
9 215
10 777
12 149
17 566
26 780
40 662
53 494
76 944
82 389
Retained Earnings
344
2 215
13 703
20 132
24 347
33 227
8 516
17 141
20 239
32 327
37 147
25 882
18 142
67 840
82 254
72 962
Additional Paid In Capital
1 297
1 884
1 651
1 586
1 587
38 554
10 883
21 824
27 742
38 478
55 375
75 453
96 923
110 889
108 339
102 883
Unrealized Security Profit/Loss
973
27
51
0
1 463
1 393
1 602
454
249
98
31
304
275
2 498
2 496
2 873
Treasury Stock
0
0
0
0
0
7
7
7
7
7
7
7
7
7
7
7
Other Equity
0
1 001
921
1 027
0
0
0
0
0
0
0
0
239
207
388
499
Total Equity
23 793
N/A
22 642
-5%
16 554
-27%
22 404
+35%
15 701
-30%
8 165
-48%
6 185
-24%
13 436
+117%
18 522
+38%
18 391
-1%
35 818
+95%
76 041
+112%
119 400
+57%
99 241
-17%
105 907
+7%
115 675
+9%
Total Liabilities & Equity
44 250
N/A
87 521
+98%
58 090
-34%
30 389
-48%
21 968
-28%
19 673
-10%
16 405
-17%
28 845
+76%
36 741
+27%
61 440
+67%
69 805
+14%
138 293
+98%
176 303
+27%
189 857
+8%
155 305
-18%
156 697
+1%
Shares Outstanding
Common Shares Outstanding
5
5
7
9
9
10
13
18
22
24
35
50
81
85
143
165
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
3
0
22
11
11
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett